ALX Oncology raises $105mm in Series C round

14:40 EST 13 Feb 2020 | Elsevier Business Intelligence

Immuno-oncology firm ALX Oncology raised $105mm through its Series C round. Vivo Capital led and was joined by other first-t...

Original Article: ALX Oncology raises $105mm in Series C round


More From BioPortfolio on "ALX Oncology raises $105mm in Series C round"

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...